LipC (rv0220) is an immunogenic cell surface esterase of mycobacterium tuberculosis

Infection and Immunity

Volumn 80, Issue 1, 2012, Pages 243-253

  Shen, Guomiao ^a   Singh, Krishna ^a   Chandra, Dinesh ^a,e   Carole, Serveau Avesque ^c   Maurin, Damien ^c,f   Canaan, Stéphane ^c   Singla, Rupak ^d   Behera, Digambar ^d   Laal, Suman ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c Centre National de la Recherche Scientifique   (France)

^d Lala Ram Sarup Institute of Tuberculosis and Respiratory Diseases   (India)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f INSTITUT DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; ESTERASE; LIPC PROTEIN; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; CYTOKINE; EPITOPE; ESTER; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; BACTERIAL GROWTH; CELL WALL; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE COURSE; EPITOPE MAPPING; HUMAN; HUMORAL IMMUNITY; IMMUNOMODULATION; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUBERCULOSIS; ANIMAL; BACTERIAL MEMBRANE; BLOOD; CHEMISTRY; EPITHELIUM CELL; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROLYSIS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PROTEIN MOTIF; RABBIT; SECRETION;

AMINO ACID MOTIFS; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; CELL WALL; CYTOKINES; EPITHELIAL CELLS; EPITOPE MAPPING; ESTERASES; ESTERS; HIV INFECTIONS; HUMANS; HYDROLYSIS; IMMUNODOMINANT EPITOPES; MACROPHAGES; MEMBRANE PROTEINS; MYCOBACTERIUM TUBERCULOSIS; RABBITS; RECOMBINANT PROTEINS; TUBERCULOSIS;

EID: 84857089765     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05541-11     Document Type: Article

References (60)

1. Alcaro MC, Peroni E, Rovero P, Papini AM. 2003. Synthetic peptides in the diagnosis of HIV infection. Curr. Protein Pept. Sci. 4:285-290.
2. Bermudez LE, Goodman J. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64:1400-1406.
3. Berthet FX, et al. 1998. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 282:759-762.
4. Bowden MG, et al. 2002. Is the GehD lipase from Staphylococcus epidermidis a collagen binding adhesin? J. Biol. Chem. 277:43017- 43023.
5. Canaan S, et al. 2004. Expression and characterization of the protein Rv1399c from Mycobacterium tuberculosis: a novel carboxyl esterase structurally related to the HSL family. Eur. J. Biochem. 271:3953-3961.
6. Cole ST, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
7. Cooper AM, Magram J, Ferrante J, Orme IM. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186: 39-45.
8. Daleke MH, et al. 2011. Conserved Pro-Glu (PE) and Pro-Pro-Glu (PPE) protein domains target LipY lipases of pathogenic mycobacteria to the cell surface via the ESX-5 pathway. J. Biol. Chem. 286:19024-19034.
9. Daniel J, et al. 2004. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J. Bacteriol. 186:5017-5030.
10. Deb C, et al. 2006. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J. Biol. Chem. 281:3866-3875.
11. Dong Y, et al. 2005. Antibody responses to MS, MPT51 and PPE-C discriminate between latent and incipient sub-clinical TB, p 146-150. In Proceedings of the 40th US-Japan Conference on Tuberculosis and Leprosy, Seattle, WA.
12. Gilham D, Lehner R. 2005. Techniques to measure lipase and esterase activity in vitro. Methods 36:139-147.
13. Gomara MJ, Haro I. 2007. Synthetic peptides for the immunodiagnosis of human diseases. Curr. Med. Chem. 14:531-546.
14. Henderson B, Nair S, Pallas J, Williams MA. 2011. Fibronectin: a multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS Microbiol. Rev. 35:147-200.
15. Houghton RL, et al. 2002. Use of multiepitope polyproteins in serodiagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 9:883- 891.
16. Huet C. 1994. Production of polyclonal antibodies in rabbits, p 257-268. In Celis JE (ed), Cell biology: a laboratory handbook, vol 2. Academic Press, Inc, San Diego, CA.
17. Ireton GC, et al. 2010. Identification of Mycobacterium tuberculosis antigens of high serodiagnostic value. Clin. Vaccine Immunol. 17:1539-1547.
18. Kanaujia GV, Garcia MA, Bouley DM, Peters R, Gennaro ML. 2003. Detection of early secretary antigenic target-6 antibody for diagnosis of tuberculosis in non-human primates. Comp. Med. 53:602- 606.
19. Kinhikar A, et al. 2006. Mycobacterium tuberculosis malate synthase is a laminin binding adhesin. Mol. Microbiol. 60:999-1013.
20. Kinhikar A, et al. 2010. Potential role for ESAT-6 in dissemination of Mycobacterium tuberculosis via human lung epithelial cells. Mol. Microbiol. 75:92-106.
21. Kitaura H, Ohara N, Naito M, Kobayashi K, Yamada T. 2000. Fibronectin-binding proteins secreted by Mycobacterium avium. APMIS 108:558-564.
22. Kremer L, Maughan WN, Wilson RA, Dover LG, Besra GS. 2002. The Mycobacterium tuberculosis antigen 85 complex and mycolyltransferase activity. Lett. Appl. Microbiol. 34:233-237.
23. Krishnan N, Robertson BD, Thwaites G. 2010. The mechanisms and consequences of the extra-pulmonary dissemination of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 90:361-366.
24. Kurashima K, et al. 1997. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am. J. Respir. Crit. Care Med. 155: 1474-1477.
25. Lun S, Bishai WR. 2007. Characterization of a novel cell wall-anchored protein with carboxylesterase activity required for virulence in Mycobacterium tuberculosis. J. Biol. Chem. 282:18348-18356.
26. Manca C, Paul S, Barry CE III, Freedman VH, Kaplan G. 1999. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect. Immun. 67:74-79.
27. Marques MA, Chitale S, Brennan PJ, Pessolani MC. 1998. Mapping and identification of the major cell wall-associated components of Mycobacterium leprae. Infect. Immun. 66:2625-2631.
28. Mishra KC, et al. 2008. Functional role of the PE domain and immunogenicity of the Mycobacterium tuberculosis triacylglycerol hydrolase LipY. Infect. Immun. 76:127-140.
29. Munoz-Elias EJ, McKinney JD. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11:638-644.
30. Murphy DJ. 2001. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 40:325- 438.
31. Rachman H, et al. 2006. Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect. Immun. 74: 1233-1242.
32. Rosenau F, et al. 2010. Lipase LipC affects motility, biofilm formation and rhamnolipid production in Pseudomonas aeruginosa. FEMS Microbiol. Lett. 309:25-34.
33. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5:725-738.
34. Samanich K, Belisle JT, Laal S. 2001. Homogeneity of antibody responses in tuberculosis patients. Infect. Immun. 69:4600-4609.
35. Samanich KM, et al. 1998. Delineation of human antibody responses to culture filtrate antigens of Mycobacterium tuberculosis. J. Infect. Dis. 178: 1534-1538.
36. Sartain MJ, Slayden RA, Singh KK, Laal S, Belisle JT. 2006. Disease state differentiation and identification of tuberculosis biomarkers via native antigen profiling. Mol. Cell. Proteomics 5:2102-2113.
37. Schue M, et al. 2010. Two cutinase-like proteins secreted by Mycobacterium tuberculosis show very different lipolytic activities reflecting their physiological function. FASEB J. 24:1893-1903.
38. Shah DS, Russell RR. 2004. A novel glucan-binding protein with lipase activity from the oral pathogen Streptococcus mutans. Microbiology 150: 1947-1956.
39. Shen G, Behera D, Bhalla M, Nadas A, Laal S. 2009. Peptide-based antibody detection for tuberculosis diagnosis. Clin. Vaccine Immunol. 16:49-54.
40. Singh G, Jadeja D, Kaur J. 2010. Lipid hydrolizing enzymes in virulence: Mycobacterium tuberculosis as a model system. Crit. Rev. Microbiol. 36: 259-269.
41. Singh KK, et al. 2005. Antigens of Mycobacterium tuberculosis recognized by antibodies during incipient, subclinical tuberculosis. Clin. Diagn. Lab. Immunol. 12:354-358.
42. Singh KK, et al. 2003. Combined use of serum and urinary antibody for diagnosis of tuberculosis. J. Infect. Dis. 188:371-377.
43. Singh KK, et al. 2009. Peptides of a novel Mycobacterium tuberculosisspecific cell-wall protein for immunodiagnosis of TB. J. Infect. Dis. 200: 571-581.
44. Singh KK, Zhang X, Patibandla AS, Chien P Jr, Laal S. 2001. Antigens of Mycobacterium tuberculosis expressed during preclinical tuberculosis: serological immunodominance of proteins with repetitive amino acid sequences. Infect. Immun. 69:4185- 4191.
45. Srinivas M, et al. 2008. Functional characterization of the phospholipase C activity of Rv3487c and its localization on the cell wall of Mycobacterium tuberculosis. J. Biosci. 33:221-230.
46. Steingart KR, et al. 2009. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin. Vaccine Immunol. 16:260-276.
47. Steingart KR, et al. 2007. A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis. Thorax 62:911-918.
48. Talaat AM, Lyons R, Howard ST, Johnston SA. 2004. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc. Natl. Acad. Sci. U. S. A. 101:4602- 4607.
49. Tielen P, et al. 2010. Extracellular enzymes affect biofilm formation of mucoid Pseudomonas aeruginosa. Microbiology 156:2239-2252.
50. Timm J, et al. 2003. Differential expression of iron-, carbon-, and oxygenresponsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc. Natl. Acad. Sci. U. S. A. 100:14321-14326.
51. van Crevel R, Ottenhoff TH, van der Meer JW. 2002. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15:294-309.
52. Volkman HE, et al. 2010. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327: 466-469.
53. Wanchu A, et al. 2008. Biomarkers for clinical and incipient tuberculosis: performance in a TB-endemic country. PLoS One 3:e2071- e2079.
54. WHO. 2006. Diagnostics for tuberculosis: global demand and market potential. World Health Organization, Geneva, Switzerland.
55. WHO. 2009. Global tuberculosis control 2009: epidemiology, strategy, financing. World Health Organization, Geneva, Switzerland.
56. WHO. 2008. Laboratory-based evaluation of 19 commercially available rapid diagnostic tests for tuberculosis. World Health Organization, Geneva, Switzerland.
57. Wilson RA, Maughan WN, Kremer L, Besra GS, Futterer K. 2004. The structure of Mycobacterium tuberculosis MPT51 (FbpC1) defines a new family of non-catalytic alpha/beta hydrolases. J. Mol. Biol. 335:519-530.
58. Wolfe LM, Mahaffey SB, Kruh NA, Dobos KM. 2010. Proteomic definition of the cell wall of Mycobacterium tuberculosis. J. Proteome Res. 9:5816-5826.
59. Zahrt TC, Deretic V. 2000. An essential two-component signal transduction system in Mycobacterium tuberculosis. J. Bacteriol. 182:3832-3838.
60. Zhang M, et al. 2005. Expression and characterization of the carboxyl esterase Rv3487c from Mycobacterium tuberculosis. Protein Expr. Purif. 42:59-66.